The revised price target suggests that Sartorius Group is valued at 26.5 times its estimated 2025 EV/EBITDA, which is consistent with the historical range of 20 to 30 times. The analysts at Morgan ...
As always, we will present our results in a way that I will start with some highlights, and then Florian will expand on the financial results in quite some detail on the Sartorius Group.
The dividend will be paid on April 1, 2025. This press release contains forward-looking statements about the future development of the Sartorius Group. Forward-looking statements are subject to ...
Hosted on MSN1mon
Morgan Stanley lifts Sartorius stock rating, raises target to EUR340The revised price target suggests that Sartorius Group is valued at 26.5 times its estimated 2025 EV/EBITDA, which is consistent with the historical range of 20 to 30 times. The analysts at Morgan ...
The dividend will be paid on April 1, 2025. This press release contains forward-looking statements about the future development of the Sartorius Group. Forward-looking statements are subject to known ...
Sartorius Stedim Biotech SA / Key word(s): Annual Results/Quarter Results Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2024 28-Jan-2025 / 07:04 CET/CEST ...
The Sartorius Group is a leading international partner of biopharmaceutical research and the industry. With innovative laboratory instruments and consumables, the Group's Lab Products & Services ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results